Fish Oil Supplementation in Women With Gestational Diabetes

Status Unknown status

Clinical Trial Summary

Gestational diabetes is the development of diabetes during pregnancy. Left untreated, gestational diabetes and preeclampsia can lead to serious -- or even fatal -- complications for both mother and child. Some evidence suggesting omega-3 fatty acids might help protect women from two serious pregnancy complications -- gestational diabetes and preeclampsia. Omega-3 fatty acids, in particular Docosahexaenoic acid (DHA), help a pregnant woman give her developing baby every advantage in life starting in-utero. Recent studies suggested that the biologic processes underlying the observed associations may involve epigenetic changes, specifically DNA methylation. In this study the investigators aimed to examine the effect of fish oil supplementation in women with gestational diabetes mellitus on newborn outcomes and insulin like growth factor 1 DNA methylation.

Clinical Trial Description

Gestational diabetes is the development of diabetes during pregnancy. According to the National Institutes of Health, gestational diabetes occurs in about 5 percent of all pregnancies in the United States, resulting in about 200,000 cases a year. Treatment involves dietary measures, exercise and, in some cases, insulin injections. All pregnant women should be taking a prescribed pre-natal vitamin, and should also supplement with fish oil or another source of omega-3 fatty acids to help support the nervous system of their developing child.

Left untreated, gestational diabetes and preeclampsia can lead to serious -- or even fatal -- complications for both mother and child. In diabetic pregnancies there is an increased risk of birth defects. Some evidence suggesting omega-3 fatty acids might help protect women from two serious pregnancy complications -- gestational diabetes and preeclampsia. Omega-3 fatty acids, in particular Docosahexaenoic acid (DHA), help a pregnant woman give her developing baby every advantage in life starting in-utero. In general the omega-3 fatty acids found in fish help the cardiovascular system, the brain (including moods), and even the brain and eyes of a developing baby. The risk of pre-term delivery and low birth weight is three and a half times higher when mothers are deficient in DHA. Recent studies suggested that the biologic processes underlying the observed associations may involve epigenetic changes, specifically DNA methylation. In this study the investigators aimed to examine the effect of fish oil supplementation in women with gestational diabetes mellitus on newborn outcomes and insulin like growth factor 1 DNA methylation. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02371343
Study type	Interventional
Source	Dr. Sami Ulus Children's Hospital
Contact	Dilek Dilli, Assoc Prof
Phone	+905422368250
Email	dilekdilli2@yahoo.com
Status	Unknown status
Phase	N/A
Start date	March 2015
Completion date	September 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00826904` - Regulation Of Maternal Fuel Supply And Neonatal Adiposity
Recruiting	`NCT06157684` - Timing of Ambulation and Infant Birth Weight in Gestational Diabetes	N/A
Completed	`NCT02713568` - Estimation of Fetal Weight by MR Imaging to PREdict Neonatal MACROsomia (PREMACRO Study)	N/A
Recruiting	`NCT03451838` - Prediction of Fetal Macrosomia by US
Recruiting	`NCT02473991` - Correlation Between Placental Thickness in the Second and Third Trimester and Fetal Weight	N/A
Completed	`NCT02523222` - Prophylactic Dextrose Gel for Newborns at High-risk for Hypoglycemia	N/A
Completed	`NCT03002246` - Automated Fetal Weight Estimation: A Multicenter Validation Using Fractional Limb Volume
Recruiting	`NCT04399434` - Gut Microbiota, SCFAs and Glucolipid Metabolism in Pregnant Women With Abnormal Fetal Size and Their Newborns
Completed	`NCT00625781` - Treatment of Impaired Glucose Tolerance in Pregnancy	N/A
Completed	`NCT00190320` - DAME: Induction of Labor or Waiting for Suspicion Fetal Macrosomia	Phase 4
Not yet recruiting	`NCT06268392` - A Comparative Study of AI Methods for Fetal Diagnostic Accuracy in Ultrasound
Recruiting	`NCT06067685` - Investigating the Relationship Between Triglycerides and Fetal Overgrowth in Gestational Diabetes
Completed	`NCT03232294` - Fetal Front-abdominal Wall Thickness and Perinatal Outcome	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.